Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Glenmark Pharmaceuticals Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

20 Aug 2016 Reuters Investment Profile 12 $20.00

Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financial Analysis Review

Glenmark Pharmaceuticals Ltd. (GLENMARK) - Financial Analysis Review Summary Glenmark Pharmaceuticals Ltd. (Glenmark Pharmace...

23 Aug 2016 GlobalData 60 $300.00

Thomson Reuters Stock Report - Glenmark Pharmaceuticals Ltd (GLENMARK-IN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

23 Aug 2016 Thomson Reuters Stock Report 11 $25.00

Wright Investors Service Comprehensive Report for Glenmark Pharmaceuticals Ltd

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

17 Aug 2016 Wright Reports 61 $75.00

MOSL: GLENMARK PHARMA 1QFY17 (Neutral)-Operational performance in line-PAT beat due to forex gains

GLENMARK PHARMA 1QFY17: Operational performance in line; PAT beat due to forex gains (GNP IN, Mkt Cap USD3.4b, CMP INR846, T...

16 Aug 2016 Motilal Oswal Securities Ltd. 10 $104.00

Spark Capital: 1QFY17 outlook review of Glenmark Pharmaceuticals (Rating: SELL, TP: Rs. 807)

1QFY17 outlook review of Glenmark Pharmaceuticals (Rating: SELL, TP: Rs. 807) How does our one year outlook change? We...

16 Aug 2016 Spark Capital Advisors(India) Private Limited 6 $46.00

Glenmark Pharmaceuticals_Q1FY17 Result Update

Glenmark Pharmaceuticals (GNP IN) reported in-line with expectation numbers. Sales growth was aided by good growth in almost ...

16 Aug 2016 IndiaNivesh Securities Pvt Ltd 7 $69.00

Glenmark Pharmaceuticals (GNP) - Qtr. Update - Dated - August 13, 2016

Glenmark Pharma (Bloomberg: GNP IN; HOLD; TP – Rs 900; 6% upside from CMP of Rs 846) Glenmark’s (GNP) Q1 EBITDA growth (up 5%...

16 Aug 2016 Axis Capital Limited 7 $69.00

MOSL: ANNUAL REPORT THREADBARE (ART) | GLENMARK PHARMA FY16-Ex equity dilution, net worth stagnant for six years

Glenmark Pharmaceuticals’ (GNP) FY16 annual report analysis highlights an increase in net worth under IGAAP from INR23.6b in ...

02 Aug 2016 Motilal Oswal Securities Ltd. 16 $150.00

Spark Capital: Glenmark Pharmaceuticals – FY16 annual report analysis

Glenmark Pharmaceuticals – FY16 annual report analysis Business highlights: 13 ANDAs were filed during the year includi...

21 Jul 2016 Spark Capital Advisors(India) Private Limited 7 $58.00